NCT04342182 - Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 8, 2020

Primary Completion Date

July 1, 2020

Study Completion Date

September 30, 2020

Conditions

COVID-19

Interventions

BIOLOGICAL

Convalescent plasma

"Infusion of plasma retrieved from donors with a history of PCR proven symptomatic COVID.~Plasma will be administered according to the Erasmus MC KIS protocol regarding the use of blood products"

Trial Locations (18)

3000 CA

Erasmus Medical Center, Rotterdam

Unknown

NoordWest Ziekenhuisgroep, Alkmaar

Onze Lieve Vrouwen Gasthuis, Amsterdam

Rijnstate Ziekenhuis, Arnhem

Reinier de Graaf Gasthuis, Delft

Catharina Ziekenhuis, Eindhoven

Medisch Spectrum Twente, Enschede

Groene Hart Ziekenhuis, Gouda

Martini Hospital, Groningen

Spaarna Gasthuis, Haarlem

Alrijne Ziekenhuis, Leiderdorp

Sint Antonius Ziekenhuis, Nieuwegein

Canisius-Wilhelmina Hospital, Nijmegen

Maasstad Ziekenhuis, Rotterdam

ZorgSaam Hospital, Terneuzen

Haaglanden Medisch Centrum, The Hague

Bernhoven Hospital, Uden

VieCuri, Venlo